XCL1

XCL1 Full Name

chemokine (C motif) ligand 1

XCL1 Introduction

XCL1, officially named chemokine (C motif) ligand 1, possesses several widely recognized alternate names in academic and clinical research. Its most common alias is lymphotactin, the earliest identified nomenclature for this unique C-type chemokine. It is also referred to as SCYC1, reflecting its classification as a small inducible cytokine subfamily C member 1. Unlike other classic chemokines, XCL1 has no redundant splicing variants with distinct naming tags. These unified aliases facilitate consistent research communication across immunology, virology and oncology studies, eliminating terminology confusion in molecular database annotations and experimental documentation.Human XCL1 is encoded by a gene located on the long arm of chromosome 1, belonging to the rare C-chemokine subfamily with unique structural features. Differing from conventional chemokines with four conserved cysteine residues, XCL1 retains only two cysteines, forming its distinct C motif structure. This protein exhibits metamorphic conformational plasticity, interconverting between a monomeric classic chemokine fold and an alternative dimeric structure under varying temperature and salt conditions. The canonical structure consists of three-stranded beta sheets and a single alpha helix, laying a unique structural foundation for its diverse biological activities and receptor binding specificity.

Figure 1. XCL1 gene locus.

Physiological and Pathological Roles of XCL1
Under physiological conditions, XCL1 maintains immune surveillance and tissue immune balance by orchestrating lymphocyte trafficking. In pathological states, its abnormal expression is closely linked to inflammatory disorders, viral infections and tumor progression. Dysregulated XCL1 signaling may trigger excessive immune infiltration and chronic inflammation in damaged tissues. In tumor microenvironments, XCL1 modulates anti-tumor immune responses by regulating immune cell infiltration. Its dual roles in immune protection and pathological injury render it a promising biomarker and potential therapeutic target for immune-related diseases and malignancies.

Cellular Expression and Secretion of XCL1
XCL1 displays strict tissue-specific and inducible expression patterns in multiple immune cells under both physiological steady-state and external stimulated conditions. Unlike most ubiquitous chemokines, XCL1 maintains extremely low basal expression in resting immune cells and is rapidly upregulated upon immune activation and inflammatory stress. It is predominantly secreted by fully activated CD8+ cytotoxic T cells and natural killer (NK) cells, which serve as its major cellular sources during acute and adaptive immune responses. Moderate and inducible expression is also detected in mature dendritic cells, invariant NKT cells and specific lymphocyte subsets triggered by pathogen infection or pro-inflammatory cytokines. After intracellular synthesis and maturation, XCL1 is actively released into the extracellular microenvironment to exert both paracrine and autocrine immune regulatory effects. This tightly controlled cellular expression and secretion mode enables XCL1 to precisely modulate local immune cell recruitment and microenvironment homeostasis during pathogen invasion and tissue inflammation.

Alternate Names for XCL1

XCL1; chemokine (C motif) ligand 1; LTN; ATAC; LPTN; SCM1; SCM-1; SCM1A; SCYC1; SCM-1a